Clinical Trials › NCT06072703
RecruitingNA
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
Sponsored by The Methodist Hospital Research Institute
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 29
Target enrollment
1
U.S. states
Oct 2023
Start date
Dec 2027
Expected completion
Interventions / Treatments
Magstim Rapid2 System
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Texas1 site
Houston
MS centers in Texas
Compare treatment centers near a trial site by center type, providers and trials.
View Texas centers